logo
logo
ELMD stock ticker logo

Electromed, Inc.

AMEX•ELMD
CEO: Mr. James L. Cunniff
セクター: Healthcare
業種: Medical - Devices
上場日: 2010-08-13
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
連絡先情報
500 Sixth Avenue NW, New Prague, MN, 56071, United States
952-758-9299
smartvest.com
時価総額
$196.09M
PER (TTM)
21.6
4
配当利回り
--
52週高値
$30.73
52週安値
$17.73
52週レンジ
44%
順位24Top 10.8%
5.7
F-Score
改良版 Piotroski 分析
10年ファンダメンタル
堅調 • 5.7 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2016-2025

財務ダッシュボード

Q2 2026 データ

売上高

$18.90M+0.00%
直近4四半期の推移

EPS

$0.33+0.00%
直近4四半期の推移

フリーCF

$3.29M+0.00%
直近4四半期の推移

2026 Q2 決算ハイライト

主なハイライト

Revenue Growth Strong Six months net revenues reached $35.784M, marking a 15.7% increase driven by Homecare segment growth.
Net Income Surges Six months net income totaled $4.897M, reflecting 42.3% growth due to higher revenue and gross profit.
Gross Margin Expansion Gross profit margin improved to 78.3% for six months, up from 78.0% previous period on increased device sales.
New Credit Facility Secured Established $10.0M senior secured revolving credit facility in December 2025; zero principal balance outstanding currently.

リスク要因

Operating Cash Flow Decline Cash provided by operations fell to $3.195M for six months, down from $5.460M due to working capital changes.
Hospital Sales Volatility Quarterly hospital revenue decreased 9.4% due to lower capital equipment orders impacting short-term sales consistency.
International Revenue Drop Other revenue segment saw sharp quarterly decline of 52.3%, attributed to lower international distributor purchases.
Share Repurchase Spending Financing activities used $3.768M cash, primarily funding $3.766M in common stock repurchase programs during the period.

見通し

Liquidity Sufficient Forecast Working capital of $36.192M plus available borrowings expected to meet liquidity needs for next twelve months.
R&D Tax Acceleration Company plans to accelerate remaining R&D deductions over one year, estimating $428,000 cash tax reduction in 2026.
Capital Expenditure Funding Planned equipment purchases expected to be financed via operating cash flows or borrowings under new credit facility.
Accounting Standard Evaluation Evaluating impact of recently issued accounting standards ASU 2023-09 and ASU 2024-03 for future adoption periods.

同業比較

売上高 (TTM)

ARAY stock ticker logoARAY
$436.97M
-3.6%
INGN stock ticker logoINGN
$348.67M
+3.9%
HCAT stock ticker logoHCAT
$311.14M
+1.5%

粗利益率 (最新四半期)

MXCT stock ticker logoMXCT
92.4%
+16.1pp
SGHT stock ticker logoSGHT
87.3%
+2.5pp
TLSI stock ticker logoTLSI
86.7%
-2.8pp

主要指標

銘柄コード
時価総額
PER (TTM)
ROE (TTM)
負債比率
CATX$371.61M-3.5-39.1%1.1%
VMD$356.83M23.410.9%7.4%
SGHT$198.20M-5.1-55.7%35.0%

長期トレンド

直近4四半期
売上高
純利益
営業キャッシュフロー
4四半期売上高CAGR
6.4%
安定成長
4四半期純利益CAGR
13.4%
収益性の着実な向上
キャッシュフロー安定性
100%
優れたキャッシュフローの実績

深度リサーチ

次回決算:2026年5月11日
|
EPS:-
|
売上高:-
財務データ
決算説明会
財務レポート
ニュース
損益計算書
バランスシート
キャッシュフロー計算書
財務比率
変化率
損益計算書
直近12ヶ月
データなし